Aurobindo Pharma Share Price Target 2026: Aurobindo Pharma Ltd has reported a 2 per cent rise in consolidated profit after ...
June 18 (Reuters) - The U.S. Federal Trade Commission is requiring Aurobindo Pharma Limited to divest four different generic ...
The Food and Drug Administration granted tentative approval to AuroBindo Pharma for dolutegravir, a drug intended to treat patients with HIV, reported Business Standard. Dolutegravir is the generic ...
India-based drug manufacturer Aurobindo Pharma plans to focus on increased Abbreviated New Drug Application filings and new differentiated product launches in the United States to maintain its growth.
Aurobindo Pharma Ltd. on Friday said its arm CuraTeQ Biologics has received a compliance notice from Health Canada's Biologics and Radiopharmaceutical Drugs Directorate for its bevacizumab biosimilar ...